Fresenius | FRE - Los Gastos De Explotación

Precio De Mercado
44.62
Cambio Diario
0.43 0.97%
Mensual
0.27%
Anual
12.82%
Q2 Expectativa
43.45




Los Gastos De Explotación Cambio Fecha
Akzo Nobel EUR 2.16B 95M 2025-12
Alcon AG USD 2.41B 123M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
BASF EUR 14.21B 372M 2025-12
Bayer EUR 10.33B 126M 2025-12
Beiersdorf EUR 4.16B 212M 2025-12
DaVita Healthcare Partners USD 3.04B 3.61B 2025-12
Demant DKK 9.63B 241M 2025-12
E.ON EUR 20.13B 4.41B 2025-12
Essilor EUR 13.09B 1.07B 2025-12
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
Getinge SEK 9.99B 2.3B 2024-12
Givaudan CHF 3B 107M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GN Store Nord DKK 4.11B 490M 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.78B 669M 2025-12
Novartis USD 9.8B 61M 2025-12
Philips EUR 4.38B 405M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
RWE EUR 3.79B 1.47B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12